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Background: Public health genomics is an emerging multidisciplinary approach, which aims to integrate genome-based
knowledge in a responsible and effective way into public health. Despite several surveys performed to evaluate
knowledge, attitudes and professional behaviors of physicians towards predictive genetic testing, similar surveys
have not been carried out for public health practitioners. This study is the first to assess knowledge, attitudes
and training needs of public health professionals in the field of predictive genetic testing for chronic diseases.
Methods: A self-administered questionnaire was used to carry out a cross-sectional survey of a random sample
of Italian public health professionals.
Results: A response rate of 67.4% (797 questionnaires) was achieved. Italian public health professionals have the
necessary attitudinal background to contribute to the proper use of predictive genetic testing for chronic
diseases, but they need additional training to increase their methodological knowledge. Knowledge significantly
increases with exposure to predictive genetic testing during postgraduate training (odds ratio (OR) = 1.74, 95%
confidence interval (CI) = 1.05–2.88), time dedicated to continuing medical education (OR = 1.53, 95% CI = 1.14–2.04) and
level of English language knowledge (OR = 1.36, 95% CI = 1.07–1.72). Adequate knowledge is the strongest predictor of
positive attitudes from a public health perspective (OR = 3.98, 95% CI = 2.44–6.50). Physicians show a lower level of
knowledge and more public health attitudes than other public health professionals do. About 80% of public health
professionals considered their knowledge inadequate and 86.0% believed that it should be improved through specific
postgraduate training courses.
Conclusions: Specific and targeted training initiatives are needed to develop a skilled public health workforce competent
in identifying genomic technology that is ready for use in population health and in modeling public health genomic
programs and primary care services that need to be developed, implemented and evaluated.
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The decade following the completion of the human gen-
ome project has been marked by divergent claims about
the utility of genomics for public health purposes. Some
public health advocates contend that interventions based
on environmental changes will be more effective than
those focused on individual behavior change. By con-
trast, those supportive of a role for public health genom-
ics argue that increasing knowledge of genomics and* Correspondence: paolo.villari@uniroma1.it
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unless otherwise stated.molecular pathology could unlock effective diagnostic
techniques and treatments, as well as better target public
health interventions [1-6].
Public health practitioners from academic, government
and other organizations have taken a proactive leader-
ship role in assessing the relevance of DNA technology
to population health and to community health interven-
tions [7-10]. Among the priorities of the public health gen-
omics movement, there is the assurance of an adequate
public health capacity on genomics [11-13]. Appropriate
capacity building and the development of a skilled public
health workforce competent in the differentiation betweenal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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health and technology that is not ready for prime time is a
fundamental issue to ensure the appropriate use of genomic
information for health promotion and prevention of dis-
eases. Predictive genetics have currently few applications in
clinical practice, but the scenario is likely to change in the
future. In Italy, as well as in other countries, predictive tests
have raised interest in public health, particularly in the case
of high-penetrance genetic variants associated with com-
mon types of cancer (breast/ovarian and colorectal cancer)
and familiar hypercholesterolemia. These predictive genetic
tests, if used appropriately, have been demonstrated to be
efficacious and cost-effective [14].
Many surveys have been conducted to assess know-
ledge, attitudes and professional behavior of physicians
toward predictive genetic testing for chronic diseases
[15-37]. This study is the first to be carried out on public
health practitioners. It was conducted in Italy, where a
specific public health genomics policy is being developed
[38]. Predictive medicine is one of the four macro-areas
of intervention of the 2010–2012 National Preventive
Plan, which foresees the drawing up of a dedicated Na-
tional Plan for Public Health Genomics (PHG-NP). This
national plan, which defines the actions to be taken at
central level in order to implement a stewardship gov-
ernance model to best translate genomics in clinical
practice, has been recently approved [39].
Methods
Participants
A link to a self-administered anonymous online question-
naire was e-mailed in 2010 to 1,200 public health profes-
sionals randomly selected from the register of the Italian
Society of Hygiene, Preventive Medicine and Public Health
(S.It.I.). An accompanying cover letter outlined the details
of the study and assured the participants of anonymity. The
online questionnaire could only be submitted once per per-
son. Up to two reminder e-mails containing the link to the
online questionnaire were sent to non-responders 3 and
6 months after the initial e-mail. To maximize the response
rate, telephone calls were made to all subjects before each
of the follow-up mailings. A total of 60 public health pro-
fessionals could not be contacted by telephone because
their numbers were not available.
The design of the study allowed the research team to
identify non-responders and to compare their demo-
graphic and professional characteristics with those of the
responders. After the comparisons were made, the iden-
tification codes were destroyed, thereby maintaining
total anonymity for all participants.
The study was in compliance with the Declaration of
Helsinki and ethical approval was obtained by the
Ethical Committee of Azienda Policlinico Umberto I
(Rome, Italy).Survey instrument
The questionnaire (see the complete questionnaire in
the Additional file 1 for more details) comprised a series
of questions designed to assess socio-demographic and
professional characteristics, knowledge and public health
attitudes towards predictive genetic tests for chronic dis-
eases, and self-estimated level of knowledge and training
needs.
Knowledge about predictive genetic tests for chronic
diseases was investigated through seven questions using
a three-point Likert scale (“agree”, “uncertain”, and “dis-
agree”). The same Likert three-point scale was used to
assess the participants’ public health attitudes, i.e. atti-
tudes that may predispose individuals to adopt or reject
specific public health-related behaviors [40]. Public
health professionals were finally asked to assess their
own level of knowledge on a four-point scale (“in-
adequate”, “sufficient”, “good”, and “excellent”) and
answer four questions (each with “yes/no” answers) on
training needs.
Extensive pre-administration piloting was conducted
with a convenience sample of 40 physicians similar to
the study population to ensure practicability, validity and
interpretation of answers. On the basis of the comments
and suggestions obtained from the pilot study, the ques-
tionnaire was revised before distribution to the study
sample. Instrument revision included changes to ques-
tionnaire item wording and format. Items were only in-
cluded in the survey instrument if there was consensus
on their meaning.
Statistical analysis
Multiple logistic regression was performed to identify
predictors of knowledge (Model 1) and positive public
health attitudes (Model 2). For the purpose of analysis,
the outcome variables “knowledge” and “attitudes” ori-
ginally consisting of multiple categories were collapsed
into two levels. In brief, for the knowledge variable,
responders were divided into those who agreed with all
correct responses versus all others, while for attitudes,
public health practitioners were grouped into those who
showed a positive public health attitude in all questions
versus all others. The following predictor variables were
initially tested in both models: geographical area of pro-
fessional activity; gender; age; medical degree; profes-
sional activity; exposure to predictive genetic testing
during undergraduate/postgraduate courses; knowledge
of the English language; internet access in the workplace;
hours per week dedicated to continuing medical educa-
tion; and reception in the previous year of specific in-
formative from institutional sources. In the model
concerning attitudes, the variable “adequate knowledge
of genetic testing”—dichotomized as above—was also
included.
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the strategy suggested by Hosmer and Lemeshow [41].
Each variable was examined by univariate analysis using
the appropriate statistical test (Student’s t-test or χ2
test), and was included in the model when the P-value
was less than 0.25. Subsequently, multivariate logistic re-
gression with backward elimination of any variable that
did not contribute to the model on the grounds of the
Likelihood Ratio test (cut-off, P = 0.05) was performed.
Variables whose exclusion altered the coefficient of the
remaining variables were kept in the model. Interaction
terms were tested using a cut-off significance level of
0.15. Adjusted odds ratios (ORs) and 95% confidence in-
tervals (CIs) were calculated. All statistical calculations
were performed using Stata version 8.0 (Stata Corpor-
ation, College Station, TX, USA).
Results
Out of the original sample of 1,200 public health profes-
sionals 797 answered giving an overall response rate of
67.4% (see Table 1 for demographic and professional char-
acteristics of the responding public health professionals).
Responders and non-responders were comparable in
terms of demographic and professional characteristics
(gender, age, type of degree and professional activity;
P >0.05). Most responders were female (53.9% vs.
52.6% of non-responders), with a mean age of 47.5
(±10.9) years (48.7 years for non-responders), had a
medical degree (79.7% vs. 75.9%) and were employed
in Public Health Services of the Italian National Health
Service (64.1% vs. 69.0%).
No statistically significant differences were detected
between our sample and the study population, since
52.8% of the S.It.I. members are female and have a simi-
lar age distribution (S.It.I., personal communication,
2012). The proportions of S.It.I. members with a medical
degree and employed in Public Health Services of the
Italian NHS were 77.1% and 66.4%, respectively.
A minority of responders were exposed to predictive
genetic testing during undergraduate (20.3%) or post-
graduate (24.3%) training. Knowledge of the English
language appeared to be relatively poor, as 41.4% of sub-
jects indicated “very low” or “low” levels of English. The
majority of the sample (55.2%) dedicated 1–5 hours per
week to continuing medical education. Less than one
third of the responders (26.9%) received specific inform-
ative about predictive genetic testing from institutional
sources in the previous year (Table 1).
Knowledge of predictive genetic testing for chronic
diseases appeared adequate among public health profes-
sionals in Italy (Table 2). Almost all responders recognized
that predictive genetic tests could identify individuals at
higher risk of developing diseases, and the majority cor-
rectly agreed with definitions of analytic validity (70.6%),clinical validity (63.0%) and clinical utility (68.0%) of
predictive genetic tests. Three-quarters of the sample
acknowledged the importance of genetic counseling,
but only half were aware of the availability of evidence-
based recommendations/guidelines for some predictive
genetic tests (Table 2). Only 10.2% of the responders
answered all seven questions about predictive genetic
testing correctly and this knowledge was significantly asso-
ciated with exposure to predictive genetic testing during
postgraduate training (OR = 1.74, 95% CI = 1.05–2.88), with
time dedicated to continuing medical education (OR = 1.53,
95% CI = 1.14–2.04) and with level of English language
knowledge (OR = 1.36, 95% CI = 1.07–1.72). Being a
physician was a negative predictor of adequate knowledge
(OR = 0.54, 95% CI = 0.32–0.92) (Model 1 in Table 3).
Most of responders showed positive attitudes—from a
public health perspective—towards predictive genetic
testing for chronic diseases (Table 4). The majority of
the responders disagreed that predictive genetic tests
should be introduced into clinical and public health
practice even without health interventions with proven
efficacy (57.9%) and 55.7% of them agreed that predictive
genetic testing should be performed only if there is evi-
dence of cost-effectiveness. The vast majority of public
health professionals recognized that predictive genetic
testing should be included in wider prevention strategies
taking into account other available health interventions
(90.5%) and acknowledged the importance of ethical,
legal and social implications (82.5%) (Table 4). A total of
24.3% of public health professionals showed a positive
public health attitude in all six questions, and this
dichotomization was used to identify as significant predic-
tors (i) adequate knowledge (OR = 3.98, 95% CI = 2.44–
6.50), (ii) exposure to predictive genetic testing during
underunder training (OR = 1.53, 95% CI = 1.03–2.26) and
(iii) time dedicated to continuing medical education
(OR = 1.31, 95% CI = 1.06–1.61). Physicians were more
likely to show positive public health attitudes than
other public health professionals were (OR = 2.17, 95%
CI = 1.34–3.51) (Model 2 in Table 3).
About 80% of public health professionals considered their
knowledge on predictive genetic testing for chronic diseases
to be inadequate. The majority of responders agreed there
is a need for increased training on predictive genetic testing
for chronic diseases during undergraduate (90.8%) or post-
graduate courses (94.6%). Almost all responders (94.6%) be-
lieved that their knowledge should be improved, and 86.0%
believed that specific post-training courses in predictive
genetic testing for chronic diseases should be implemented
(data not shown).
Discussion
A specific health policy concerning public health genom-
ics is currently being developed in Italy by the Ministry
Table 1 Demographic and professional characteristics of
the responding public health professionals
Variables N. %
Geographical area (785)a
North 244 31.1
Center 184 23.4
South 225 28.7
Islands 132 16.8
Gender (790)a
Female 426 53.9
Male 364 46.1
Age, years (790)a
≤30 52 6.6
31-40 191 24.2
41-50 182 23.0
51-60 297 37.6
≥61 68 8.6
Type of degree (786)a
Medicine 626 79.7
Biology 83 10.6
Nursing 27 3.4
Other health professions degrees 25 3.1
Other degrees 25 3.2
Exposure to predictive genetic testing during undergraduate
training (797)a
No 635 79.7
Yes 162 20.3
Exposure to predictive genetic testing during postgraduate
training (797)a
No 603 75.7
Yes 194 24.3
English language knowledge (789)a
Very low 126 16.0
Low 200 25.3
Intermediate 270 34.2
Good 153 19.4
Excellent 40 5.1
Internet available in the workplace (797)a
No 44 5.5
Yes 753 94.5
Hours per week dedicated to continuing medical education
(797)a
<1 114 14.3
1-5 440 55.2
6-10 166 20.8
>10 77 9.7
Table 1 Demographic and professional characteristics of
the responding public health professionals (Continued)
Reception in the previous year of specific information
concerning predictive genetic testing from institutional
sources (797)a
No 583 73.1
Yes 214 26.9
aNumber of public health professionals responding to the question.
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Health Genomics (PHG-NP) has recently been drawn-
up that addresses in depth how to translate genomics
knowledge into public health [39]. To achieve the
strategic objectives of the PHG-NP, systematic health
technology assessment of predictive genetic test for
complex diseases, promotion of genomic education
among physicians and the general public and the devel-
opment of capacity building among all potential stake-
holders for the health care appropriate provision and
management of predictive genetic testing will be needed.Table 2 Knowledge of the responding public health
professionals regarding predictive genetic testing for
chronic diseases
Variables Agree Uncertain Disagree
% % %
Predictive genetic tests are able to
identify genotypes which themselves
do not cause the disease but modify
the risk of developing it (788)a
86.6 9.0 4.4
Lifestyles, socioeconomic factors and
pollution exposure cannot modify or
influence the risk of disease due to a
genetic predisposition (788)a
14.2 10.4 75.4
The analytic validity of a predictive genetic
test is related to the accuracy of the
laboratory test in identifying a specific
genetic characteristic (788)a
70.6 25.6 3.8
The clinical validity of a predictive genetic
test is related to the power of the test
to quantify the risk of developing the
disease (787)a
63.0 24.1 12.8
The clinical utility of a predictive genetic
test is related to the power of the test
to improve the health status of the
subject (787)a
68.0 20.8 11.2
Performing predictive genetic tests should
not necessarily be associated with genetic
counseling that includes information,
informed consent, and discussion of the
results (787)a
11.8 13.2 75.0
Recommendations/guidelines produced
by national/international organizations
about the use of some predictive genetic
tests already exist (786)a
47.1 49.1 3.8
Note: Percentages referring to correct answers are in bold.
aNumber of public health professionals responding to the question.
Table 3 Determinants of public health professionals’
knowledge and attitudes concerning predictive genetic
testing for chronic diseases
Variables OR 95% CI
Model 1: Knowledge about predictive
genetic testinga.
Hours per week dedicated to continuing
medical education (<1 = 0; 1-5 = 1;
6-10 = 2; > 10 = 3)b
1.53 1.14 – 2.04
Exposure to predictive genetic tests during
postgraduate training (No = 0; Yes = 1)
1.74 1.05 – 2.88
English language knowledge (Very low = 0;
low = 1; intermediate = 2; good = 3;
excellent = 4)b
1.36 1.07 – 1.72
Medical degree (No = 0; Yes = 1) 0.54 0.32 – 0.92
Model 2: Attitudes about predictive
genetic testingc.
Hours per week dedicated to continuing
medical education (<1 = 0; 1-5 = 1;
6-10 = 2; > 10 = 3)b
1.31 1.06 – 1.61
Exposure to cancer genetic tests during
undergraduate training (No = 0; Yes = 1)
1.53 1.03 – 2.26
Medical degree (No = 0; Yes = 1) 2.17 1.34 – 3.51
Knowledge about predictive genetic
testing (Not adequate = 0;
adequate = 1)a
3.98 2.44 – 6.50
Note: OR: Odds Ratio. CI: Confidence Interval.
aPhysicians were classified as those who answered correctly all questions on
predictive genetic testing (Table 2) vs. all others.
bVariable modeled as ordinal because linearity was assessed.
cPublic health professionals were divided into those who showed positive
public health attitudes in all questions (Table 4) vs. all others.
Table 4 Public health attitudes of the responding public
health professionals towards predictive genetic testing
for chronic diseases
Variables Agree Uncertain Disagree
% % %
Predictive genetic tests increase prevention
opportunities for chronic diseases (788)a
76.5 17.5 6.0
Predictive genetic tests able to identify an
increased risk of developing a disease
should be introduced in the clinical and
public health practice even without health
interventions with proven efficacy (788)a
22.0 20.2 57.9
Predictive genetic tests should be
introduced in the clinical and public
health practice only if economic
evaluations show cost-effectiveness ratios
favorable compared with alternative
health interventions (787)a
55.7 26.0 18.3
Authoritative and evidence based
guidelines are needed for the appropriate
use of predictive genetic tests (788)a
95.2 4.2 0.6
Predictive genetic tests can contribute
efficaciously to health promotion and
disease prevention only if included in
wider strategies taking into account the
other available health interventions (788)a
90.5 6.9 2.7
The implementation of predictive genetic
testing in the clinical and public health
practice, being a medical matter, should
not take into account ethical, legal and
social implications (788)a
8.1 9.4 82.5
Note: Percentages referring to answers denoting a positive public health
attitude are in bold.
aNumber of public health professionals responding to the question.
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ing a proactive role to integrate genome-based know-
ledge into public health in a responsible and effective
way, also anticipating in a certain way the increase in
the health service requirements that is likely to occur in
the future [14].
To our knowledge, this survey is the first to be con-
ducted on public health practitioners. The results show
that the Italian public health community has the neces-
sary attitudinal background to contribute to the proper
use of predictive genetic testing for chronic diseases, but
that an additional training to increase methodological
knowledge is needed. Despite more positive public health
attitudes, public health physicians have more gaps in their
knowledge than other public health professionals (who are
mainly biologists), reflecting possible deficiencies in the
genetics components of current medical curricula in Italy.
Compared with Italian physicians, who previously showed
significant training needs in the field of efficacy, effective-
ness and economic evaluation of health interventions
[42,43], public health attitudes towards predictive gen-
etic testing appear to be more positive among public
health practitioners. For example, the percentage of
public health professionals who agree that the selectionof predictive genetic testing to be delivered to the
population should be based on the principles of effi-
cacy and cost-effectiveness are higher than those found
among Italian physicians in another survey [44]. Glo-
bally, the public health community in Italy appears to
be more prepared than physicians for a responsible
and appropriate introduction of DNA-technology into
health care and public health practice.
Previous surveys carried out in the United States among
health educators showed that education and training influ-
ence public health genomics knowledge and attitudes
[45,46]. The results of the present survey are consistent
with these findings. Exposure to predictive genetic testing
during undergraduate and postgraduate training and time
dedicated to continuing medical education are significant
determinants of both knowledge and positive attitudes.
Adequate knowledge is the strongest predictor of positive
public health attitudes and there is a high level of
interest in further education and training to improve
knowledge and skills in this field. Overall, the results
of this survey clearly indicate that there is a strong
need for specific and targeted training initiatives for
the public health workforce.
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indicate that education alone does not necessarily translate
into effective and appropriate adoption of innovative prac-
tice [47,48]. Organizational changes are needed within the
health care system to provide these services effectively and
efficiently. In theory, predictive genetic testing can be used
in population screening programs led by public health pro-
fessionals or for early case detection and intervention in
primary care settings. Today, there is a limited evidence
base to support either genetic population screening
programs or a personalized individual predictive gen-
etic testing, but this scenario is likely to change to a
large extent in the future [14,49-60]. The small number
of clinical geneticists in practice will limit their ability
to participate in the care associated with an expending
menu of genetic tests [51]. Public health professionals
could and should play an important role in the “honest
broker” evaluation process that can discriminate those
genomic applications that can improve health from those
that are likely to result in potential harm and unnecessary
health care expenditure through premature use. Most im-
portantly, public health professionals can contribute to the
modeling of public health genomic programs and primary
care services that need to be developed, implemented, and
evaluated [61-63].
The main limitation of this survey concerns the
generalizability of its results. While the sample surveyed
was representative of the study population and the re-
sponse rate was high, differences between the Italian
and other European and non-European public health
workforces are likely to exist. Despite the fact that
public health is one of the established specialties in the
European Union (EU) [64] and, consequently, a spe-
cialist trained in one EU country will be recognized
as a specialist in all EU countries, non-uniformity of
public health curricula is a recognized problem [65].
Moreover, public health today requires a multidiscip-
linary workforce [66], and the non-medical component
of the public health workforce – in Italy represented
mainly by biologists and people with health profession
degrees – could vary among countries. Therefore, the
knowledge, public health attitudes and training needs
in the field of public health genomics should also be
assessed in other countries, hopefully within specific
national health policy frameworks.
Conclusions
In conclusion, the results of this survey show that the
Italian public health community has the necessary attitu-
dinal background to contribute to the proper introduc-
tion and use of predictive genetic testing for chronic
diseases, but some knowledge gaps exist that should be
filled through appropriate training. A specific policy of
public health genomics is currently being developed at anational level by the Ministry of Health in Italy [38], with
three major mainstays: (i) systematic health technology as-
sessments of genetic tests for complex diseases; (ii) promo-
tion of genomic education in physicians and capacity
building; and (iii) promotion of basic genomic health liter-
acy for the general population. The implementation of such
a policy is an obligation for public health professionals.
They will lose credibility if, on the one hand, they promote
health literacy enabling and empowering individuals for de-
cision making, while, on the other hand, they ignore gen-
omic and genetic knowledge, thus missing opportunities to
provide evidence-based public health interventions.
Additional file
Additional file 1: Questionnaire on knowledge, attitudes and
training needs of public health professionals on the use of
predictive genetic tests.
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